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ABSTRACT  
Objectives: Inappropriate use of ceftriaxone has been reported to increase treatment cost among patients. In addition, inappropriate use is a 
threat for resistance development. We assessed utilization of ceftriaxone among selected public and private hospitals in Dar es Salaam 
Tanzania. 
Methods: Retrospective study was conducted from February to May 2017. Total of 600 patients’ medication records were included. Chi square 
test was used to compare appropriateness use of ceftriaxone between the hospitals. Significance level was set at 0.05 and the confidence level at 
95%. 
Results: Total of 330 (55%) and 270 (45%) patients were prescribed ceftriaxone for pre-operative prophylaxis, and treatment respectively. In 
overall, ceftriaxone was significantly utilized inappropriately in private hospital (72.3%) than in public hospital (60%) p= 0.002 against the 
Tanzania standard treatment guideline. Ceftriaxone was more used inappropriately in private (87%) than the public hospital (6 9.2%) p<0.001 
for prophylaxis. In contrary, for treatment indication ceftriaxone was more used inappropriately in  public hospital (53.3%) than in private 
hospital (38.9%) p= 0.026.There were no records of sensitivity test in all the patients’ files.  
Conclusion: We report inappropriately utilization of Ceftriaxone against the Tanzanian standard treatment guideline. Private hospital was 
found to utilize ceftriaxone more inappropriately than the public hospital. We recommend further prospective studies involvin g all 
antimicrobials to be done. 
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INTRODUCTION 
Since their discoveries antimicrobials have transformed 
global healthcare and saved millions of lives. Currently the 
world is threatened by the growing burden of antimicrobial 
resistance. Common curable infections are fast becoming 
deadly because antibiotics no longer respond to the 
infections that use to respond before 1. In the United States it 
is estimated that each year at least 2 million people acquire 
serious infections with bacteria that are resistant to one or 
more of the antibiotics designed to treat those infections and 
that at least 23,000 people die each year as a result of 
antibiotic-resistant infections2. World Health 
Organization(WHO) cautions that antimicrobial resistance 
will increase healthcare costs for individuals, health systems, 
and countries if actions will not be taken 3. Use, overuse and 
misuse of antimicrobials are the reasons for the developing 
resistance 4. The current antimicrobial action plan stipulates 
optimization of antimicrobial agents as one of the strategies 
for fighting against antimicrobial resistance. Drug use 
evaluation studies have been good approaches for promoting 
the quality and optimization of drug care in the treatment 
centers.  
Ceftriaxone is a third generation bactericidal Cephalosporin 
antibiotic with wide spectrum activity and good safety 
profile. It is widely used to treat various bacterial infections 
including bronchitis, pneumonia, bone infections, abdominal 
infection, skin infections, meningitis, endocarditis, urinary 
tract infections, septicemia and surgical prophylaxis 5. Due to 
its high antibacterial activity, extensive spectrum of activity, 
low potential for toxicity it is one of the most widely used 
antibiotics 6, 7. 
Evidence from both developed and developing countries 
indicates inappropriate utilization of ceftriaxone. In 
developed countries inappropriate use of ceftriaxone is not 
as worse as in developing countries. For instance in Korea a 
study found only 34.5% of inappropriate use 8.The study in 
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tertiary hospital in Port of Spain found ceftriaxone as the 
most prescribed cephalosporin antibiotic 9. In contrary, two 
studies in Ethiopia found inappropriate use of ceftriaxone as 
high as 70% and 80% respectively 10, 11. Inappropriate use of 
ceftriaxone does not only increase treatment cost to patients 
but also may put selective pressure on bacteria to acquire 
resistance genes hence result in emergence of antibiotic 
resistance. 
Tanzania is one of the resources limited countries with high 
demand for antibiotics influenced by the high burden of 
infectious disease. Inappropriate use of ceftriaxone is likely 
to happen. Unfortunately there is limited data, thus it is not 
known to what extent is the problem. Data on utilization of 
ceftriaxone are very important especially currently where 
implementation of global antimicrobial resistance action 
plan is on the table. Therefore the present study gives an 
insight regarding utilization of ceftriaxone among selected 
public and private hospitals in Dar es salaam, Tanzania. 
These findings may pave the way for further studies to 
evaluate antimicrobial use in health facilities as the basis for 
their rational use. 
METHODS 
Study design and area 
A retrospective cross sectional study was conducted from 
February to May, 2017. The study reviewed medical records 
of patients previously admitted at Mwananyamala (public 
hospital) and Tumaini (private hospital) in Dar es Salaam 
Tanzania. The hospitals were purposively selected. 
Inclusion and exclusion criteria 
This study included medical records of all patients 
previously admitted in medical and surgical wards and 
stayed for more than 24 hours. Patients who had received at 
least one course of any dose of ceftriaxone treatment from 
January to December 2016 were included. Medication 
records that were incomplete in terms of main variables 
were excluded. 
Sample size and selection 
A WHO guideline for the study of medication use was used to 
obtain the representative sample size. A total of 600 (300 
from each hospital) patients medication records were 
purposively selected. 
Data collection procedure 
A pre-tested checklist contained information on gender, age, 
dose, frequency of administration, number of co-morbid 
conditions, number and type of co-prescribed medications 
and duration of ceftriaxone therapy was used for data 
collection. The files of patients treated with ceftriaxone were 
traced back to the records of the hospitals using the card 
numbers obtained from the inpatient registration 
documents. Data collection format was developed based on 
the WHO criteria for Drug Use Evaluation. Tanzanian 
Standard Treatment Guideline and National essential 
medicine list of 201312 was used to validate the tool for 
ceftriaxone use evaluation. Inappropriate use of ceftriaxone 
in the hospitals was determined by comparing the observed 
ceftriaxone prescribing in the patient’s file to the 
recommendations in the Tanzania national standard 
treatment guideline. 
Ethics consideration 
Ethics approval was granted by the Institutional review 
board of the Muhimbili University of Health and Allied 
Sciences (MUHAS). Permission to conduct the study in the 
selected health facilities was sought and obtained from the 
Medical Officers in charge prior data collection. In order to 
ensure confidentiality of the study participants’ data were 
entered in the computer and analyzed using code numbers 
instead of names. 
Data management and analysis 
The coded data were checked and cleaned before entered in 
to Statistical package for social sciences (SPSS) version 20 for 
analysis. Descriptive statistics and crosstabs were employed 
to assess adherence to ceftriaxone utilization. Chi square test 
was used to compare ceftriaxone use adherence between 
public and private hospitals. Significance level was set at 0.05 
and the confidence level at 95%. 
RESULTS 
A total of 600 (300 from public hospital and 300 from private 
hospital) patients’ records were included in this study. In 
both hospitals majority of participants (58.7%) had ages 
below 35 years. Few participants in public hospital had age 
beyond sixty years but in private hospital about quarter of 
participants had the age beyond sixty years. In both hospitals 
majority (57%) of all participants were females (Table 1).
 
Table 1: Socio-demographic characteristics of participants (n=600) 
Characteristics  Public hospital n (%) Private hospital n(%) 
Age (in years) 
Mean age (SD) 
14-35 
36-60 
≥60 
 
28 (2.5) 
195 (65) 
82    (27.3) 
23    (7.7) 
 
32 (3.6) 
157   (52.3) 
69     (23) 
74     (24.7) 
Sex 
Male 
Female 
 
122 (40.7) 
178 (59.3) 
 
135 (45) 
165 (55) 
Prophylaxis indication of ceftriaxone 120 (36.4) 210 (63.6) 
Therapeutic indication of ceftriaxone 180 (66.7%) 90 (33.3) 
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Common indications of ceftriaxone in the hospitals 
A total of 330 patients (55%) (120 from public hospital and 
210 from private hospital) were prescribed ceftriaxone for 
pre-operative prophylaxis. Two hundred and seventy (45%) 
patients (180 from public hospital and 90 from private 
hospital) were prescribed ceftriaxone for the treatment of 
bacterial infection. Ceftriaxone was prescribed for treatment 
of Pneumonia, Septicemia, urinary tract infection, bacterial 
meningitis, chronic kidney diseases (CKD), and pelvic 
inflammatory disease (PID). About 16.4% of the 
prescriptions were for the conditions not indicated in the 
standard treatment guideline. In terms of indication 
Pneumonia was the most common disease treated by 
ceftriaxone (Figure 1). 
 
 
 
Overall standard treatment compliance of ceftriaxone 
therapy 
In overall, ceftriaxone was significantly inappropriately 
prescribed in private hospital (72.3%) than in public 
hospital (60%) p=0.002. In pre-surgical prophylaxis, 
ceftriaxone was significantly inappropriately used in private 
hospital (87%) than the public hospital (69.2%) p=0.0001 
(Table 2). The inappropriate prescribing was due to longer 
duration of administration (3-5days) than which is stated in 
the Standard Treatment guideline. Among patients 
prescribed ceftriaxone for treatment of bacterial infections, 
inappropriate use was significantly more in the public 
hospital than in private hospital. Inappropriate use was for 
the duration prescribed, frequency and wrong indication. 
Ceftriaxone compliance with Tanzania standard treatment 
guideline was more for pre-surgery prophylaxis than in 
treatment of bacterial infections in all the hospitals (Figure 
2).
 
Table 2: Ceftriaxone utilization; Standard treatment guideline compliance between the two hospitals 
Prescribing pattern  Public Hospital n 
(%) (n=300) 
Private hospital n 
(%) (n=300) 
P-value  
Overall STG compliance    
 
0.002 
         Appropriate utilization 121 (40) 83 (27.7) 
         Inappropriate utilization 179 (60) 217 (72.3) 
STG  prophylactic use  compliance     
 
<0.0001 
          Appropriate utilization 37 (30.8) 28 (13) 
          Inappropriate  utilization 83 (69.2%) 182 (87%) 
STG therapeutic use compliance      
 
0.026 
     Appropriate utilization 84 (46.7) 55 (61.1) 
     Inappropriate utilization 96 (53.3%) 35 (38.9%) 
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Figure 1: Diseases for which ceftriaxone was indicated 
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DISCUSSION 
We report ceftriaxone utilization in selected public and 
private hospitals in Dar es Salaam, Tanzania. The major 
findings of this study were, (i) overall poor adherence to 
Tanzania standard treatment guideline (>50%) with regard 
to ceftriaxone utilization in both hospitals,(ii) ceftriaxone 
was commonly used for pre-operative prophylaxis, and (iii) 
pneumonia being the most common indication where 
ceftriaxone was prescribed.  
High inappropriate utilization of ceftriaxone found in this 
study indicates a problem in rational use of ceftriaxone in 
the hospitals. Inappropriate use of ceftriaxone indicates 
negligence to standard treatment guideline adherence. In 
addition, the high inappropriate utilization pose threats for 
resistance development. There may be a challenge of 
standard treatment guideline availability and use in both 
hospitals which may have been contributed to the findings. 
It is important that emphasis on the importance of adhering 
to STG become the priority among healthcare workers 
especially for antibiotics bearing in mind the globe threat to 
antimicrobial resistance. In addition the ministry 
responsible for health should make sure that STGs are made 
available and utilized to all health facilities The findings are 
similar to the findings from Ethiopia 13, 14 indicating a 
challenge in sub-Saharan Africa. 
Inappropriate use of ceftriaxone was significantly found to 
be more in private hospital than in public hospital. This 
difference might have been due to less availability of STGs in 
private hospitals than in public hospital although this was 
not part of this study. Influence by profit making in private 
setting than in public setting may also contribute to the 
observed difference. Regardless of the hospital setting 
rational use of antibiotics need to be the agenda to all health 
facilities.  These results are similar to the comparative 
retrospective study between public and private hospital 
done by Tariku et.al in Ethiopia 15. 
In this study ceftriaxone was found to be commonly used for 
preoperative prophylactic. More inappropriate use of 
ceftriaxone in this indication was detected in both hospitals 
although adherence to STG was significantly more in public 
hospital than in private hospital. According to Tanzania 
Standard Treatment guideline normally prophylactic 
antibiotic should be used 30 minutes or 1 hour before the 
surgical procedure and should be used not more than 24 
hours unless susceptible bacterial infections diagnosed. We 
found ceftriaxone prescribed between 3 to 7 days pre-
surgery without any susceptible bacterial infection recorded 
contrary to Tanzania standard treatment guideline. This 
unnecessary use of ceftriaxone adds on treatment costs to 
patients and may put pressure on this potential antibiotic for 
resistance development. 
Ceftriaxone was also found to be prescribed for treatment of 
various bacterial infections. In this case ceftriaxone was 
found to be used inappropriately significantly more in the 
public based hospital than in private hospital. The 
inappropriate uses were due to wrong duration of 
treatment, wrong frequency, wrong dose and wrong 
indication according to Tanzania standard treatment 
guideline. Although ceftriaxone was prescribed 
appropriately for treatment of pneumonia, sepsis, Urinary 
tract infection, Pelvic inflammatory disease, and meningitis, 
a significant number of inappropriate uses are of concern. 
For instance, contrary to Tanzania standard treatment 
guideline, ceftriaxone was prescribed to diseases such as 
chronic obstructive pulmonary disorders (COPD), dyspepsia, 
typhoid fever, chronic kidney diseases (CKD) and 
cardiovascular diseases without any record of co-morbidity 
requiring such a prescription. This contributed to more than 
sixteen percent of all the ceftriaxone prescriptions used for 
therapeutic. Moreover there no any record of bacteria 
susceptibility test requested in all patients. Pneumonia was 
the leading disease where ceftriaxone was mostly 
prescribed. These findings are similar to those of Getasewet 
al in Dessie referral hospital Ethiopia 16.  
The limitation for this study could be the fact that it was a 
retrospective that only assessed records of patients who 
were prescribed ceftriaxone thus we couldn’t monitor 
treatment outcomes. Some of the information also might 
have been not reported in the patient’s records thus the 
actual inappropriate use of ceftriaxone could have been 
underestimated or overestimated. 
CONCLUSION 
Ceftriaxone was mostly found to be utilized inappropriately 
against the Tanzanian treatment guideline. Private hospital 
was found to utilize ceftriaxone more inappropriately than 
the public hospital. We recommend further prospective 
study involving all antimicrobials to be done.  
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Figure 2: Overall standard treatment guideline compliace 
with respect to ceftriaxone indication in the two hospitals  
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